ESR2 and breast fibrocystic disease: In fact, studies in ER-β knockout mice (βERKO) revealed an abnormal epithelial growth, the overexpression of Ki67 and severe cystic breast disease, indicating a stimulatory role of ER-α and an inhibitory effect of ER-β in the proliferation of different estrogen-responsive tissues [25].